DOBI Medical International , Inc.

Industry:	Medical Devices & Equipment
Revenues:	$1.2 Million
Employees:	14

Description

DOBI Medical International, headquartered in Mahwah, NJ, is a technology-based medical device company that is developing a unique and potentially lifesaving means for the improved diagnosis of cancer through the detection of abnormal vascularization changes associated with tumors. Our first application of this technology has been to develop an adjunctive tool to mammography - a key diagnostic imaging modality widely used to aid in the diagnosis of breast cancer. While mammography has long been considered an important tool for breast cancer detection, it has been shown to have numerous limitations. The process is often painful, irradiates the patient, is limited in its ability to identify breast cancer in its earliest stages, and is often unable to differentiate malignant from benign tumors. While still the most common tool for detecting breast cancer, the mammogram also has limited applicability to millions of women under the age of 40 and women on hormone-replacement therapy, due to the lack of contrast in x-ray images of dense breast tissue. The American Cancer Society estimates that 5 to 10 percent of mammography tests are abnormal or inconclusive, necessitating further testing that can be painful, invasive, and expensive. Our dynamic optical breast imaging (DOBI®) system, the ComfortScan® system, is a noninvasive, non-ionizing medical-equipment product designed to assist physicians in the diagnosis of breast cancer. We are able achieve this on a cost-effective basis by potentially providing new, image-based, physiological information never before available.